| RS730880404 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Atrial septal defect 5 |
| RS730880406 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 5, Dilated cardiomyopathy 1R |
| RS730880410 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Dilated cardiomyopathy 1R |
| RS730880411 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS730880420 |
CAV3
|
Health Risk |
Likely pathogenic |
— |
| RS730880422 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Caveolinopathy |
| RS730880427 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, RASopathy |
| RS730880428 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730880433 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730880434 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RASopathy |
| RS730880437 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Cardiovascular phenotype |
| RS730880438 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Cardiovascular phenotype |
| RS730880439 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS730880440 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, GLA-related disorder |
| RS730880441 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS730880442 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS730880443 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880444 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880447 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880449 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880450 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS730880451 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS730880452 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880453 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS730880454 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS730880455 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS730880460 |
HRAS
|
Health Risk |
Pathogenic |
Costello syndrome, 6 conditions |
| RS730880469 |
KRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, 12 conditions |
| RS730880470 |
KRAS
|
Health Risk |
Likely pathogenic |
— |
| RS730880471 |
KRAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 4, Cardiofaciocutaneous syndrome 2 |
| RS730880472 |
KRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neoplasm, Neoplasm |
| RS730880475 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS730880479 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS730880483 |
LAMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Danon disease, Danon disease |
| RS730880485 |
LAMP2
|
Health Risk |
Pathogenic |
— |
| RS730880490 |
LAMP2
|
Health Risk |
Pathogenic |
— |
| RS730880492 |
LAMP2
|
Health Risk |
Pathogenic |
Cardiomyopathy, Danon disease |
| RS730880493 |
LAMP2
|
Health Risk |
Pathogenic |
— |
| RS730880494 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, LAMP2-related disorder |
| RS730880496 |
LAMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Danon disease, Danon disease |
| RS730880497 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Danon disease |
| RS730880498 |
LAMP2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS730880500 |
MAP2K1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, MAP2K1-related disorder |
| RS730880502 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS730880503 |
MAP2K1
|
Health Risk |
Pathogenic/Likely pathogenic |
MAP2K1-related disorder, RASopathy |
| RS730880507 |
MAP2K1
|
Health Risk |
Likely pathogenic |
— |
| RS730880508 |
MAP2K1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS730880509 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiofaciocutaneous syndrome 4 |
| RS730880513 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730880516 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS730880517 |
MAP2K2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 1, RASopathy |
| RS730880518 |
MAP2K2
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS730880522 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS730880523 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730880526 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880530 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880531 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880533 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730880535 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880538 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730880539 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS730880541 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730880542 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730880544 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS730880545 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880546 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880551 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction cardiomyopathy, Cardiovascular phenotype |
| RS730880552 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS730880553 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS730880555 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 4 |
| RS730880557 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS730880558 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880560 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS730880563 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880564 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS730880565 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880566 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730880568 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS730880569 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS730880574 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880575 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880576 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880578 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS730880580 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880581 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS730880582 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS730880584 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880586 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS730880589 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880590 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880592 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730880594 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880595 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS730880597 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880598 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730880600 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS730880601 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730880602 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730880603 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Asymmetric septal hypertrophy |
| RS730880604 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |